Topchoice Medical Co., Inc.

SHSE:600763 Rapport sur les actions

Capitalisation boursière : CN¥21.5b

Topchoice Medical Croissance future

Future contrôle des critères 1/6

Topchoice Medical devrait augmenter ses bénéfices et son chiffre d'affaires de 16.7% et de 11.2% par an respectivement. Le BPA devrait croître de de 16.7% par an. Le rendement des capitaux propres devrait être 13.3% dans 3 ans.

Informations clés

16.7%

Taux de croissance des bénéfices

16.7%

Taux de croissance du BPA

Healthcare croissance des bénéfices23.1%
Taux de croissance des recettes11.2%
Rendement futur des capitaux propres13.3%
Couverture par les analystes

Good

Dernière mise à jour07 Nov 2024

Mises à jour récentes de la croissance future

Topchoice Medical Co., Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Oct 31
Topchoice Medical Co., Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Earnings Update: Topchoice Medical Co., Inc. (SHSE:600763) Just Reported And Analysts Are Trimming Their Forecasts

Apr 30
Earnings Update: Topchoice Medical Co., Inc. (SHSE:600763) Just Reported And Analysts Are Trimming Their Forecasts

Recent updates

Topchoice Medical Co., Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Oct 31
Topchoice Medical Co., Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Is Topchoice Medical (SHSE:600763) Using Too Much Debt?

Oct 26
Is Topchoice Medical (SHSE:600763) Using Too Much Debt?

Topchoice Medical Co., Inc. (SHSE:600763) Shares Could Be 45% Below Their Intrinsic Value Estimate

Sep 25
Topchoice Medical Co., Inc. (SHSE:600763) Shares Could Be 45% Below Their Intrinsic Value Estimate

Topchoice Medical Co., Inc.'s (SHSE:600763) Shares May Have Run Too Fast Too Soon

Sep 09
Topchoice Medical Co., Inc.'s (SHSE:600763) Shares May Have Run Too Fast Too Soon

Topchoice Medical's (SHSE:600763) Returns On Capital Not Reflecting Well On The Business

Aug 14
Topchoice Medical's (SHSE:600763) Returns On Capital Not Reflecting Well On The Business

Is Topchoice Medical (SHSE:600763) A Risky Investment?

Jul 12
Is Topchoice Medical (SHSE:600763) A Risky Investment?

Topchoice Medical Co., Inc.'s (SHSE:600763) Intrinsic Value Is Potentially 73% Above Its Share Price

Jun 05
Topchoice Medical Co., Inc.'s (SHSE:600763) Intrinsic Value Is Potentially 73% Above Its Share Price

There's Reason For Concern Over Topchoice Medical Co., Inc.'s (SHSE:600763) Massive 27% Price Jump

May 21
There's Reason For Concern Over Topchoice Medical Co., Inc.'s (SHSE:600763) Massive 27% Price Jump

Earnings Update: Topchoice Medical Co., Inc. (SHSE:600763) Just Reported And Analysts Are Trimming Their Forecasts

Apr 30
Earnings Update: Topchoice Medical Co., Inc. (SHSE:600763) Just Reported And Analysts Are Trimming Their Forecasts

Topchoice Medical (SHSE:600763) Will Be Hoping To Turn Its Returns On Capital Around

Apr 28
Topchoice Medical (SHSE:600763) Will Be Hoping To Turn Its Returns On Capital Around

Prévisions de croissance des bénéfices et des revenus

SHSE:600763 - Estimations futures des analystes et données financières antérieures (CNY Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/20263,7517237951,02911
12/31/20253,33262054589212
12/31/20242,9845428688510
9/30/20242,895487350861N/A
6/30/20242,894506367870N/A
3/31/20242,880505292813N/A
12/31/20232,847500335840N/A
9/30/20232,764545421784N/A
6/30/20232,763557243704N/A
3/31/20232,739551382762N/A
12/31/20222,719548249670N/A
9/30/20222,784598224771N/A
6/30/20222,781648394867N/A
3/31/20222,804705399876N/A
12/31/20212,781703572939N/A
9/30/20212,742713673930N/A
6/30/20212,652698721897N/A
3/31/20212,523676723907N/A
12/31/20202,088493538708N/A
9/30/20201,992466497628N/A
6/30/20201,838404389545N/A
3/31/20201,733352332473N/A
12/31/20191,931466531659N/A
9/30/20191,803456545624N/A
6/30/20191,708405517574N/A
3/31/20191,632365514576N/A
12/31/20181,546332229469N/A
9/30/20181,473310218465N/A
6/30/20181,357263N/A413N/A
3/31/20181,246235N/A353N/A
12/31/20171,180217N/A347N/A
9/30/20171,108193N/A304N/A
6/30/20171,006153N/A241N/A
3/31/2017946143N/A207N/A
12/31/2016879136N/A161N/A
9/30/2016844128N/A123N/A
6/30/2016801128N/A141N/A
3/31/2016790129N/A132N/A
12/31/2015763124N/A191N/A
9/30/2015715142N/A193N/A
6/30/2015670127N/A152N/A
3/31/2015612117N/A143N/A
12/31/2014584110N/A129N/A
9/30/2014554109N/A130N/A
6/30/2014518103N/A123N/A
3/31/2014488103N/A120N/A
12/31/2013463100N/A134N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de 600763 ( 16.7% par an) est supérieure au taux d'épargne ( 2.8% ).

Bénéfices vs marché: Les bénéfices de 600763 ( 16.7% par an) devraient croître plus lentement que le marché CN ( 26.1% par an).

Croissance élevée des bénéfices: Les bénéfices de 600763 devraient augmenter, mais pas de manière significative.

Chiffre d'affaires vs marché: Le chiffre d'affaires de 600763 ( 11.2% par an) devrait croître plus lentement que le marché de CN ( 13.8% par an).

Croissance élevée des revenus: Le chiffre d'affaires de 600763 ( 11.2% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de 600763 devrait être faible dans 3 ans ( 13.3 %).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y